跳至主要内容
临床试验/CTRI/2010/091/000120
CTRI/2010/091/000120已完成3 期

Evaluation of efficacy and safety of butoconazole versus clotrimazole in the treatment of vulvovaginal candidiasis: a randomized, open label, active controlled, multicentric study.

Sun Pharmaceutical Industries Ltd.0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Female patients aged between 18 and 65 years.
  • 2. Has a primary diagnosis of vulvovaginal candidiasis.
  • 3. Patient willing to give their informed consent.

排除标准

  • 1. Pregnant, lactating women or women of childbearing age who are not using an acceptable method of birth control.
  • 2. Patients with vaginal trichomonas infection or clue cells of Gardnerella vaginalis vaginitis.
  • 3. Patients having history of recurrent vulvovaginal candidiasis, defined as occurrence of four or more than four episodes in the previous 12 months.
  • 4. Patients having hypersensitivity to imidazole derivatives.
  • 5. Patients on the treatment with an oral or intravaginal antifungal medication during a week before enrollment.
  • 6. Patients on therapy with antibiotics, systemic antimycotics, corticosteroids, or immunosuppressive drugs.
  • 7. Menstruating patients or patients expecting menses during treatment period.

研究者

相似试验